Subscribe Us

header ads

Recents

header ads

Cancer Diagnostics Market Size to Attain USD 258.54 Billion By 2030

 The cancer diagnostics market size is poised to grow by $ 258.54 billion by 2030 from $ 135.16 Billion in 2022, exhibiting a CAGR of  8.4% during the forecast period 2022 to 2030. 

Cancer Diagnostics Market Size 2022-2030

Key Takeaway:

  • By product, the consumables segment has held highest market share of 61% in 2022.
  • By technology, the IVD testing segment has generated market share of 62.3% in 2022.
  • By screening type, the laboratory tests segment held market share of 25.5% in 2022.
  • By end-user, the hospitals and clinics segment has accounted for a market share of 53% in 2022.
  • By application, the others segment has dominated the market with market share of 21.7% in 2022.
  • North America has held market share of around 41.8% in 2022.
  • Asia Pacific is expected to reach at a strongest CAGR over the forecast period.

The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.

Get a Sample: https://www.precedenceresearch.com/sample/1194

COVID-19 Impact

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Major companies operating in this area

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Becton, Dickinson and Company
  • GE Healthcare
  • QIAGEN N.V.
  • Abbott Laboratories, Inc.
  • Roche Diagnostics
  • Siemens Healthcare
  • Philips Healthcare
  • R. Bard, Inc.
  • bioMérieux SA
  • NeoGenomics Laboratories, Inc.
  • Volpara Solutions Limited
  • Hologic Inc.
  • Canon Medical Systems Corporation
  • PenRad Technologies Inc.
  • BioNTech Diagnostics GmbH
  • BioGenex

Market Segmentation

By Product

  • Consumables
    • Antibodies
    • Kits & Reagents
    • Probes
    • Other Consumables
  • Instruments
    • Pathology-based Instruments
    • Slide Staining Systems
    • Tissue Processing Systems
    • Cell Processors
    • PCR Instruments
    • NGS Instruments
    • Microarrays
    • Other Pathology-based Instruments
  • Imaging Instruments
    • CT Systems
    • Ultrasound Systems
    • MRI Systems
    • Mammography Systems
    • Nuclear Imaging Systems
  • Biopsy Instruments

By Technology

  • IVD Testing
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization (ISH)
    • Immunohistochemistry (IHC)
    • Next-generation Sequencing (NGS)
    • Microarrays
    • Flow Cytometry
    • Immunoassays
    • Other IVD Testing Technologies
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Mammography
    • Ultrasound
  • Biopsy Technique

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

By End Use

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Major highlights of Report:

  • Figures related to sales volume, market remuneration, and segmental shares
  • Featuring market dynamics
  • Growth prospects and expansion graph
  • PROCON study of direct & indirect sales channels
  • Profiles of prominent traders, dealer, and distributors in the industry

Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa

  • Industry forecasts based on region and at country level
  • Data about sales volume recorded, industry share held, and profit margins amassed
  • Overall remuneration and estimated growth rate for each regional market

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cancer Diagnostics Market 

5.1. COVID-19 Landscape: Cancer Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cancer Diagnostics Market, By Product

8.1. Cancer Diagnostics Market, by Product Type, 2022-2030

8.1.1. Consumables (Antibodies, Kits & Reagents, Probes, Other Consumables)

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Instruments (Pathology-based Instruments, Slide Staining Systems, Tissue Processing Systems, Cell Processors, Others)

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Imaging Instruments (CT Systems, Ultrasound Systems, MRI Systems, Mammography Systems, Nuclear Imaging Systems)

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Biopsy Instruments

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Cancer Diagnostics Market, By Technology

9.1. Cancer Diagnostics Market, by Technology, 2022-2030

9.1.1. IVD Testing (PCR, ISH, IHC, NGS, Microarrays, Flow Cytometry, Immunoassays)

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Imaging (MRI, CT, PET, Mammography, Ultrasound)

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Biopsy Technique

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Cancer Diagnostics Market, By Application 

10.1. Cancer Diagnostics Market, by Application, 2022-2030

10.1.1. Breast Cancer

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Colorectal Cancer

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Cervical Cancer

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Lung Cancer

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Prostate Cancer

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Skin Cancer

10.1.6.1. Market Revenue and Forecast (2019-2030)

10.1.7. Blood Cancer

10.1.7.1. Market Revenue and Forecast (2019-2030)

10.1.8. Kidney Cancer

10.1.8.1. Market Revenue and Forecast (2019-2030)

10.1.9. Liver Cancer

10.1.9.1. Market Revenue and Forecast (2019-2030)

10.1.10. Pancreatic Cancer

10.1.10.1. Market Revenue and Forecast (2019-2030)

10.1.11. Ovarian Cancer

10.1.11.1. Market Revenue and Forecast (2019-2030)

10.1.12. Others

10.1.12.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Cancer Diagnostics Market, By End Use 

11.1. Cancer Diagnostics Market, by End Use, 2022-2030

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Diagnostic Imaging Centers

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Research Institutes

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.4. Market Revenue and Forecast, by End Use (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End Use (2019-2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Illumina, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Becton, Dickinson and Company

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GE Healthcare

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. QIAGEN N.V.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott Laboratories, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Roche Diagnostics

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Siemens Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Philips Healthcare

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. R. Bard, Inc. 

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments